Early Lessons from IRA Influence on Deal-Making & Business Strategy

The life sciences industry is adapting to new realities following the implementation of the Inflation Reduction Act. This includes adjusting corporate and regulatory strategies and including provisions in licensing transactions to address the unpredictable impacts of the Act's drug price negotiation program.